Belgium's medicine price cuts risk its own innovation, economist warns

EURACTIV - Belgium does not spend unusually little on medicines compared with its larger neighbours. It spends the money badly, argues Professor Walter Van Dyck. The economist says Belgium cuts prices hard to stay within a tight budget today, then pays later in lost innovation. Read more

[Walter Van Dyck]